INFUSION CLINICAL STAFF DRIVEN HEIGHT/WEIGHT PROCESS IMPLEMENTATION TO IMPROVE CHEMOTHERAPY SAFETY

被引：0
|
作者：
Brock, Amanda [1 ]
Lynch, Mary Pat [1 ]
机构：
[1] Penn Med, Philadelphia, PA USA
来源：
ONCOLOGY NURSING FORUM | 2020年 / 47卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
53
引用
收藏
页数：2
相关论文
共 47 条
  • [41] ASO Author Reflections: Clinical Effectiveness and Safety of Transarterial Chemoembolization-Hepatic Artery Infusion Chemotherapy Plus With or Without PD-1 Inhibitors for Unresectable Hepatocellular Carcinoma: A Retrospective Study
    Chen, Yue
    Luo, Tao
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (12) : 7902 - 7903
  • [42] Clinical Nurse Specialist Influence to Increase Staff Confidence and Decrease Cesarean Section Decision to Incision Times: Use of Simulation Training to Develop a Multidisciplinary Obstetric Rapid Response Team to Improve Patient Safety
    Somberg, Christine
    Ovassapian, Maryann
    CLINICAL NURSE SPECIALIST, 2015, 29 (02) : E15 - E15
  • [43] Neoadjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Resectable BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria: A Preliminary Report of a Phase III, Randomized, Controlled Clinical Trial
    Li, S.
    Wei, W.
    Wang, Q.
    Guo, Z.
    Zou, J.
    Mei, J.
    Lu, L.
    Ling, Y.
    Xu, L.
    Chen, M.
    Lin, W.
    Wen, Y.
    Guo, R.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S5 - S6
  • [44] Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial (vol 27, pg 5183, 2020)
    Li, Shaohua
    Mei, Jie
    Wang, Qiaoxuan
    Guo, Zhixing
    Lu, Lianghe
    Ling, Yihong
    Xu, Li
    Chen, Minshan
    Zheng, Lie
    Lin, Wenping
    Zou, Jingwen
    Wen, Yuhua
    Wei, Wei
    Guo, Rongping
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 874 - 874
  • [45] Clinical Effectiveness and Safety of Transarterial Chemoembolization: Hepatic Artery Infusion Chemotherapy Plus Tyrosine Kinase Inhibitors With or Without Programmed Cell Death Protein-1 Inhibitors for Unresectable Hepatocellular Carcinoma-A Retrospective Study
    Chen, Yue
    Jia, Luyao
    Li, Yu
    Cui, Wenhao
    Wang, Jukun
    Zhang, Chao
    Bian, Chunjing
    Wang, Zhenshun
    Lin, Dongdong
    Luo, Tao
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (12) : 7860 - 7869
  • [46] Neoadjuvant hepatic arterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: A multi-center, phase 3, randomized, controlled clinical trial
    Wei, Wei
    Li, Shaohua
    Zhao, Rongce
    Cheng, Yuan
    Li, Qiang
    Lu, Lianghe
    Mei, Jie
    Shang, Changzhen
    Luo, Rui
    Pan, Mingxin
    Xiang, Bangde
    Jiang, Yuchuan
    Lei, Qiucheng
    Cao, Mingrong
    Li, Ji-Bin
    Zheng, Lie
    Chen, Huanwei
    Zhong, Jian-Hong
    Zhong, Chong
    Guo, Rongping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Neoadjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: An interim analysis of a multi-center, phase 3, randomized, controlled clinical trial.
    Li, Shaohua
    Zhong, Chong
    Li, Qiang
    Zou, Jingwen
    Wang, Qiaoxuan
    Shang, Changzhen
    Cheng, Yuan
    Cao, Mingrong
    Huang, Huakun
    Mei, Jie
    Lu, Lianghe
    Zhao, Rongce
    Lin, Wenping
    Wen, Yuhua
    Guo, Zhixing
    Ling, Yihong
    Zheng, Lie
    Wei, Wei
    Guo, Rongping
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345